Greenwich LifeSciences, Inc. (GLSI)
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
$192.83M
Mr. Snehal S. Patel
3.00
Stafford, TX
Sep 25, 2020
-18.57
$-0.79
14.13
14.13
-170,544.41%
-22.32
-0.46
40.28
38,131.27
14.13
-167.68%
-117.99%
Similar stocks (14)
Day One Biopharmaceuticals, Inc.
DAWN
Terns Pharmaceuticals, Inc.
TERN
Anavex Life Sciences Corp.
AVXL
Inozyme Pharma, Inc.
INZY
Amylyx Pharmaceuticals, Inc.
AMLX
Acumen Pharmaceuticals, Inc.
ABOS
X4 Pharmaceuticals, Inc.
XFOR
PDS Biotechnology Corporation
PDSB
MediciNova, Inc.
MNOV
Eyenovia, Inc.
EYEN
Reviva Pharmaceuticals Holdings, Inc.
RVPH
NextCure, Inc.
NXTC
Acurx Pharmaceuticals, Inc.
ACXP
Virpax Pharmaceuticals, Inc.
VRPX
ETF Exposure (17)
iShares Micro-Cap ETF
IWC
0.02164%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00594%
iShares Russell 2000 ETF
IWM
0.00237%
ProShares Ultra Russell2000
UWM
0.001182089923839876%
ProShares UltraPro Russell2000
URTY
5.8256453873616e-4%
ProShares Hedge Replication ETF
HDG
4.8002575839043376e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (14)
Day One Biopharmaceuticals, Inc.
DAWN
Terns Pharmaceuticals, Inc.
TERN
Anavex Life Sciences Corp.
AVXL
Inozyme Pharma, Inc.
INZY
Amylyx Pharmaceuticals, Inc.
AMLX
Acumen Pharmaceuticals, Inc.
ABOS
X4 Pharmaceuticals, Inc.
XFOR
PDS Biotechnology Corporation
PDSB
MediciNova, Inc.
MNOV
Eyenovia, Inc.
EYEN
Reviva Pharmaceuticals Holdings, Inc.
RVPH
NextCure, Inc.
NXTC
Acurx Pharmaceuticals, Inc.
ACXP
Virpax Pharmaceuticals, Inc.
VRPX
ETF Exposure (17)
iShares Micro-Cap ETF
IWC
0.02164%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
iShares Russell 2000 Growth ETF
IWO
0.00594%
iShares Russell 2000 ETF
IWM
0.00237%
ProShares Ultra Russell2000
UWM
0.001182089923839876%
ProShares UltraPro Russell2000
URTY
5.8256453873616e-4%
ProShares Hedge Replication ETF
HDG
4.8002575839043376e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Extended Market Index Fund
VXF
0%